Cite
HARVARD Citation
Venkatachalam, M. et al. (n.d.). 1056PEstimated costs of treatment-related adverse events (TRAEs) for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the checkmate 141 trial. Annals of oncology. p. . [Online].